Skip to main content
. 2013 Sep 3;73(12):2152–2159. doi: 10.1136/annrheumdis-2013-203742

Figure 1.

Figure 1

Changes in van der Heijde-Sharp (vdH-S) scores at week 24: total, erosion and joint space narrowing scores (A). Cumulative probability plots for total vdH-S scores (B). Patients with change of 0 or less in the total vdH-S score (C) and patients with change in excess of the smallest detectable change (SDC) (D). GLM, golimumab; MTX, methotrexate; PBO, placebo.